Zymeworks Inc (ZYME)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

540-1385 WEST 8TH AVENUE VANCOUVER, BRITISH COLUMBIA, CANADA V6H 3V9

Zymeworks Inc. operates as a clinical-stage biotechnology company. The Company discovers and develops multifunctional biotherapeutics that focuses on the treatment of cancer. Zymeworks serves pharmaceutical industry in Canada and the United States.

Data based on most recent fiscal year report
Market Cap1.88 Billion Shares Outstanding39.39 Million Avg Volume338.047 Thousand
1-Yr BETA vs S&P TR0.556 Current Ratio6.81 Quick Ratio6.81
View SEC Filings from ZYME instead.

View recent insider trading info

Funds Holding ZYME (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ZYME BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

27.5 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SACKS NATALIE CHIEF MEDICAL OFFICER

  • Officer
45,754 2020-01-16 1

KLOMPAS NEIL A CHIEF FINANCIAL OFFICER

  • Officer
9,535 2020-01-08 4

HAUSMAN DIANA CHIEF MEDICAL OFFICER

  • Officer
5,351 2020-01-08 2

POLVERINO ANTHONY J. CHIEF SCIENTIFIC OFFICER

  • Officer
28,991 2020-01-08 3

ZOTH LOTA S.

  • Director
4,090 2020-01-03 1

O'DRISCOLL KATHRYN CHIEF PEOPLE OFFICER

  • Officer
0 2019-11-08 2

RENTON HOLLINGS

  • Director
16,020 2019-11-01 1

MAHONY SUSAN

  • Director
0 2019-08-01 1

COX TROY

  • Director
0 2019-06-03 1

POON DAVID KAI YUEN SEE REMARKS

  • Officer
0 2019-05-06 1

BEDFORD NICK

  • Director
0 2019-05-06 1

HILLAN KENNETH J.

  • Director
0 2019-05-06 1

TEHRANI ALI CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
59,286 2019-03-29 1

LILLY ELI & CO

  • 10% Owner
0 2019-03-11 2

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

HAUSMAN DIANA - Officer CHIEF MEDICAL OFFICER

2020-01-08 A 332 $19.54 a 3,351 5,351.00 direct

POLVERINO ANTHONY J. - Officer CHIEF SCIENTIFIC OFFICER

2020-01-08 A 371 $19.54 a 28,991 28,991.00 direct

KLOMPAS NEIL A - Officer CHIEF FINANCIAL OFFICER

2020-01-08 A 394 $19.54 a 8,835 9,535.00 direct

POLVERINO ANTHONY J. - Officer CHIEF SCIENTIFIC OFFICER

2019-12-12 M 27,500 $15.00 a 28,620 28,620.00 direct

POLVERINO ANTHONY J. - Officer CHIEF SCIENTIFIC OFFICER

2019-12-12 M 27,500 d 82,500 28,620.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments